Predict your next investment

BenevolentAI company logo
Corporation
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
benevolent.com

See what CB Insights has to offer

Competitors

24

Business Relationships

5

Service Providers

2

BenevolentAI Competitors & Alternatives

24 Competitors

BenevolentAI has 24 competitors. BenevolentAI's competitors are Exscientia, XtalPi, BioMap, Standigm, AliveX Biotech and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

10/1/2021

IPO

$673.7M

United Kingdom

8/11/2021

Series D

$783.81M

000

Massachusetts

7/30/2021

Series A

$100M

000

China

7/6/2021

Private Equity

$78.25M

000

South Korea

6/28/2021

Seed VC - II

$10M

China

6/22/2021

Series C

$306.3M

Hong Kong

6/9/2021

Acq - Pending

$400M

Massachusetts

4/16/2021

IPO

$509.79M

Utah

4/15/2021

Series A

$6.67M

000

Canada

Latest Funding

10/1/2021

8/11/2021

7/30/2021

7/6/2021

6/28/2021

6/22/2021

6/9/2021

4/16/2021

4/15/2021

Companies

Investment Stage

IPO

Series D

Series A

Private Equity

Seed VC - II

Series C

Acq - Pending

IPO

Series A

Total Funding

$673.7M

$783.81M

$100M

$78.25M

$10M

$306.3M

$400M

$509.79M

$6.67M

Mosaic

000

000

000

000

Location

United Kingdom

Massachusetts

China

South Korea

China

Hong Kong

Massachusetts

Utah

Canada

BenevolentAI Service Providers

2 Service Providers

BenevolentAI has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Unattributed - VI

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Unattributed - VI

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Partnership data by VentureSource

BenevolentAI Partners & Customers

5 Partners and customers

BenevolentAI has 5 strategic partners and customers. BenevolentAI recently partnered with Sano Genetics, Patients Know Best, and C4X Discovery on February 2, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

2/4/2021

Partner

Sano Genetics, Patients Know Best, and C4X Discovery

United Kingdom

Sano Genetics, Patients Know Best, BenevolentAI, C4X Discovery Form Ulcerative Colitis Alliance

NEW YORK -- Sano Genetics said on Thursday that it has partnered with Patients Know Best , a UK online medical records system developer , and British drug discovery firms BenevolentAI and C4X Discovery to develop a database for ulcerative colitis research .

1

8/5/2019

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

5/1/2019

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

4/16/2019

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

4/11/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

2/4/2021

8/5/2019

5/1/2019

4/16/2019

4/11/2017

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Sano Genetics, Patients Know Best, and C4X Discovery

Country

United Kingdom

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Sano Genetics, Patients Know Best, BenevolentAI, C4X Discovery Form Ulcerative Colitis Alliance

NEW YORK -- Sano Genetics said on Thursday that it has partnered with Patients Know Best , a UK online medical records system developer , and British drug discovery firms BenevolentAI and C4X Discovery to develop a database for ulcerative colitis research .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.